Histamine H1 receptor-mediated inhibition of potassium-evoked release of 5-hydroxytryptamine from mouse forebrains. 2001

L Z Son, and K Yanai, and J I Mobarakeh, and A Kuramasu, and Z Y Li, and E Sakurai, and Y Hashimoto, and T Watanabe, and T Watanabe
Department of Pharmacology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.

The release of endogenous serotonin and dopamine from slices of mouse forebrains induced by high extracellular K(+) was examined in histamine H1 receptor knockout mice. The release of 5-hydroxytryptamine (5-HT) evoked by 30 mM K(+) significantly decreased in the presence of 10-50 microM histamine in wild-type mice, but was not inhibited in the mutant mice. Histamine H1 receptor-mediated inhibition of serotonin release in wild-type mice was also observed in the presence of thioperamide, an H3 antagonist. From these data, we postulate that endogenous histamine indirectly inhibits the release of 5-HT through H1 receptors in addition to H3 receptors. The treatment of 2 microM tetrodotoxin could partly abolish the effects of histamine on K(+)-evoked 5-HT release. Bicuculline, a GABA(A) antagonist, could reverse the histamine-induced inhibition of 5-HT release in wild-type mice, suggesting that H1 receptors facilitate the release of GABA, which in turn inhibits 5-HT release through GABA(A) receptors. The difference in the effects of d- and l-chlorpheniramine on K(+)-evoked 5-HT release in wild-type mice further supports the evidence of the function of H1 receptor modulating 5-HT release.

UI MeSH Term Description Entries
D008297 Male Males
D009433 Neural Inhibition The function of opposing or restraining the excitation of neurons or their target excitable cells. Inhibition, Neural
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011969 Receptors, Histamine H1 A class of histamine receptors discriminated by their pharmacology and mode of action. Most histamine H1 receptors operate through the inositol phosphate/diacylglycerol second messenger system. Among the many responses mediated by these receptors are smooth muscle contraction, increased vascular permeability, hormone release, and cerebral glyconeogenesis. (From Biochem Soc Trans 1992 Feb;20(1):122-5) H1 Receptor,Histamine H1 Receptors,H1 Receptors,Histamine H1 Receptor,Receptors, H1,H1 Receptor, Histamine,H1 Receptors, Histamine,Receptor, H1,Receptor, Histamine H1
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D016548 Prosencephalon The anterior of the three primitive cerebral vesicles of the embryonic brain arising from the NEURAL TUBE. It subdivides to form DIENCEPHALON and TELENCEPHALON. (Stedmans Medical Dictionary, 27th ed) Forebrain,Forebrains
D046508 Culture Techniques Methods of maintaining or growing biological materials in controlled laboratory conditions. These include the cultures of CELLS; TISSUES; organs; or embryo in vitro. Both animal and plant tissues may be cultured by a variety of methods. Cultures may derive from normal or abnormal tissues, and consist of a single cell type or mixed cell types. Culture Technique,Technique, Culture,Techniques, Culture

Related Publications

L Z Son, and K Yanai, and J I Mobarakeh, and A Kuramasu, and Z Y Li, and E Sakurai, and Y Hashimoto, and T Watanabe, and T Watanabe
July 1987, British journal of pharmacology,
L Z Son, and K Yanai, and J I Mobarakeh, and A Kuramasu, and Z Y Li, and E Sakurai, and Y Hashimoto, and T Watanabe, and T Watanabe
February 1978, Federation proceedings,
L Z Son, and K Yanai, and J I Mobarakeh, and A Kuramasu, and Z Y Li, and E Sakurai, and Y Hashimoto, and T Watanabe, and T Watanabe
June 1976, European journal of pharmacology,
L Z Son, and K Yanai, and J I Mobarakeh, and A Kuramasu, and Z Y Li, and E Sakurai, and Y Hashimoto, and T Watanabe, and T Watanabe
April 2005, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
L Z Son, and K Yanai, and J I Mobarakeh, and A Kuramasu, and Z Y Li, and E Sakurai, and Y Hashimoto, and T Watanabe, and T Watanabe
July 1982, European journal of pharmacology,
L Z Son, and K Yanai, and J I Mobarakeh, and A Kuramasu, and Z Y Li, and E Sakurai, and Y Hashimoto, and T Watanabe, and T Watanabe
January 1991, Neuroscience letters,
L Z Son, and K Yanai, and J I Mobarakeh, and A Kuramasu, and Z Y Li, and E Sakurai, and Y Hashimoto, and T Watanabe, and T Watanabe
July 1978, Science (New York, N.Y.),
L Z Son, and K Yanai, and J I Mobarakeh, and A Kuramasu, and Z Y Li, and E Sakurai, and Y Hashimoto, and T Watanabe, and T Watanabe
March 1983, Life sciences,
L Z Son, and K Yanai, and J I Mobarakeh, and A Kuramasu, and Z Y Li, and E Sakurai, and Y Hashimoto, and T Watanabe, and T Watanabe
May 1996, Pancreas,
L Z Son, and K Yanai, and J I Mobarakeh, and A Kuramasu, and Z Y Li, and E Sakurai, and Y Hashimoto, and T Watanabe, and T Watanabe
January 1993, European journal of pharmacology,
Copied contents to your clipboard!